There's a version of this article that starts with a statistic about how many people are vitamin D deficient. I'm not going to write that version.
You've seen those statistics. They haven't moved the needle. What might actually move the needle is understanding why vitamin D deficiency amplifies chronic inflammation at the cellular level - and why the story you've been telling yourself about your sun exposure, your outdoor lifestyle or your supplement routine might be leaving a significant gap.
Because I don´t think that the problem with vitamin D is awareness at this point, but assumption.
We assume we are fine, but most of them aren't.
The molecule your body uses to make both vitamin D and cholesterol - and the daily choice it has to make
Vitamin D doesn't begin as vitamin D. It begins as a molecule called 7-dehydrocholesterol - 7-DHC - synthesised in your skin. And every day, your body faces a fork in the road about what to do with it.
When UVB radiation from sunlight hits your skin at the right wavelength, 7-DHC gets converted into previtamin D3, then into vitamin D3, then processed by your liver into 25-hydroxyvitamin D - the form measured in your blood test.
When UVB isn't present - or isn't at sufficient intensity - an enzyme called DHCR7 steps in and converts that same 7-DHC into cholesterol instead.
Same molecule. Two destinations. The deciding factor is whether UVB light reaches your skin before the enzyme does.
This is why sun exposure and vitamin D status are not simply correlated - they are mechanistically linked through a shared biochemical substrate. And it's why the latitude data makes sense: cholesterol levels rise as distance from the equator increases, tracking almost exactly with declining sun exposure and declining vitamin D synthesis.
This is not a minor metabolic footnote. It's a fundamental daily allocation decision with downstream consequences for immune regulation, lipid metabolism, and inflammatory load.
Why vitamin D is not a bone health nutrient - and never really was
The bone health framing of vitamin D is a legacy of the rickets era. It's not wrong - vitamin D is essential for calcium absorption and bone mineralisation. But it's profoundly incomplete.
Vitamin D receptors (VDRs) are expressed in nearly every tissue in the body: macrophages, T-cells, B-cells, dendritic cells, the gut lining, the vascular endothelium, brain tissue, pancreatic beta cells. This is not a coincidence. It reflects the fact that vitamin D functions as a hormone, not merely a nutrient - regulating gene expression across hundreds of biological processes.
The immune regulatory role is where the research has become most compelling.
When sufficient vitamin D binds to VDRs in immune cells, it does several things simultaneously:
- It inhibits the NF-κB pathway, one of the master switches of inflammatory gene expression
- It suppresses the production of pro-inflammatory cytokines including TNF-α, IL-6, IL-1β and interferon-gamma
- It promotes the synthesis of anti-inflammatory cytokines, particularly IL-10
- It supports regulatory T-cell differentiation, which maintains immune tolerance and prevents the immune system from attacking the body's own tissues
The result is a calibrated brake on inflammatory signalling. When vitamin D is sufficient, that brake works. But when it's deficient, the brake releases - and the immune system trends toward a state of sustained, low-grade activation that doesn't resolve the way acute inflammation should.
This is the inflammatory pattern most of my clients recognise when I describe it: not sick enough to be diagnosed with something specific, but not well enough to feel genuinely good. Some of the symptoms are: fatigue that sleep doesn't fix, joint stiffness, skin that flares without obvious cause, mood that destabilises in low-light months or immune recovery that's slower than it used to be.
These are not separate problems. They are recognisable features of chronic low-grade inflammation - and vitamin D status is one of the variables quietly determining how severe that pattern becomes.
The research: what deficiency actually does to your inflammatory markers
The association between low vitamin D and elevated inflammatory markers has been documented across multiple study populations and biomarker systems.
A 2025 cross-sectional analysis published in Frontiers in Nutrition found that vitamin D deficiency was significantly associated with elevated systemic immune-inflammation index (SII) - a composite marker integrating platelet, neutrophil and lymphocyte counts that may be more sensitive than CRP alone for detecting chronic metabolic low-grade inflammation. The researchers noted that this relationship was particularly pronounced in populations with high sugar intake, suggesting an interactive effect between dietary pattern and vitamin D status on inflammatory load.
A large coronary heart disease biobank study demonstrated that individuals with both vitamin D deficiency and elevated hsCRP carried a hazard ratio of 2.82 for cardiovascular mortality - nearly triple the risk compared to those with neither marker present. Not a modest association. Nearly triple.
A 2025 systematic review examining vitamin D supplementation across cardiometabolic conditions found consistent evidence that vitamin D inhibits NF-κB signalling and downregulates TNF-α and MCP-1 - but noted that translation from animal models to clinical RCTs remains variable, likely due to heterogeneity in baseline status, dosing, and population characteristics.
The clinical picture that emerges is this: vitamin D deficiency functions as both a marker of inflammatory risk and an active amplifier of inflammatory pathology. It doesn't just reflect a problem - it worsens it.
The sun exposure problem: why your outdoor lifestyle might not be doing what you think
Here is where I want to dismantle a comfortable assumption.
Being active, being outdoors, living somewhere with a good climate - none of these things guarantee adequate vitamin D synthesis. The conditions required for meaningful UVB-driven vitamin D production are considerably more specific than most people realise.
The UVB window is narrow. UVB radiation operates at 290-315 nanometres. UVA - the wavelength that penetrates glass, causes tanning, and drives photoageing - does not produce vitamin D. UVB does not penetrate glass at all. The light coming through your car window or office window produces zero vitamin D synthesis, regardless of how bright it feels.
The sun angle matters enormously. UVB only reaches the earth's surface when the sun is high enough in the sky - roughly between 10am and 3pm in summer, with this window narrowing dramatically outside peak summer months even at southern latitudes.
Skin surface exposure is the limiting factor most people underestimate. Forearms and face - the areas typically exposed in everyday outdoor activity - represent a relatively small fraction of total body surface area. Meaningful synthesis requires more skin, more consistently.
Age reduces synthesis capacity significantly. The skin's ability to convert 7-DHC into previtamin D3 declines with age - estimates suggest roughly 50% reduction by the age of 50 compared to young adulthood, with further decline thereafter.
Skin tone extends the required exposure time. Melanin filters UVB. Individuals with darker skin require substantially longer sun exposure to produce equivalent vitamin D synthesis to those with lighter skin - often two to six times longer depending on melanin density.
A study published in June 2026 in the European Journal of Clinical Nutrition, from Newcastle University's Human Nutrition and Exercise Research Centre, followed nearly 300 adults through the summer months and found that vitamin D levels did not meaningfully improve. More than 54% of adults over 65 remained insufficient or deficient throughout summer. More than 72% of ethnic minority participants did [6]. Seasonal variation was minimal.
These are not sedentary people living in darkness. These are people operating under the same assumption most of my readers operate under: that their lifestyle is sufficient.
For higher-risk populations, the researchers concluded that summer sun cannot be relied upon as a corrective strategy. Year-round approaches are required.
I'd add this: the idea that summer tops you up for winter is further undermined by the half-life of circulating 25(OH)D, which is roughly two to three weeks. What you synthesise in July is largely metabolised by mid-August. The body does not store vitamin D the way people imagine.
Supplements and sun are not interchangeable - and the research proves it
This is the detail that surprises most people, including many practitioners.
A randomised clinical trial comparing oral vitamin D3 supplementation to narrow-band UVB phototherapy found that both methods raised serum 25(OH)D to similar levels - but at the molecular level, they produced completely opposite effects on gene expression. Oral supplementation significantly upregulated immune pathway signalling. UVB exposure significantly downregulated it. Same blood test result. Opposite biological responses.
A separate trial found that a sunlight exposure group experienced significant decreases in total cholesterol and LDL - while the vitamin D supplementation group experienced an increase in total cholesterol and HDL.
The mechanism behind these differences is still being characterised, but what it tells us clinically is that serum 25(OH)D is an incomplete readout. It measures how much of the molecule is circulating, but not the biological context in which it was produced or the full downstream effects it is generating. Sun exposure and oral supplementation are not interchangeable tools that happen to have the same label. They are different biological interventions with different effects - and the optimal strategy uses both, not one instead of the other.
What optimal vitamin D status actually looks like
The standard laboratory reference range for 25(OH)D flags deficiency at below 20 ng/mL (50 nmol/L). This is a threshold set to prevent rickets and bone disease - it is not an optimal range for immune regulation, inflammatory modulation, or metabolic function.
The range I work with clinically for anti-inflammatory outcomes is 40-60 ng/mL (100-150 nmol/L). This is the range where VDR saturation in immune tissue is more likely to be sufficient for the regulatory effects described above. Some researchers advocate for the higher end of this range, particularly for individuals with established autoimmune conditions or significant inflammatory burden.
Getting to this range requires knowing where you currently sit. The only way to know is a 25(OH)D blood test - not an estimate based on lifestyle, not a guess based on sun exposure. A test.
If testing reveals deficiency, the correction strategy needs to account for: your baseline level, your body weight (vitamin D is fat-soluble and distributes into adipose tissue), your dietary intake of co-factors - particularly magnesium (required for vitamin D activation) and vitamin K2 (which works with vitamin D to direct calcium to bone rather than soft tissue) - and your capacity for sun exposure given your age, skin type and location.
This is not a one-size-fits-all calculation. The widespread recommendation of 400-800 IU daily is appropriate for preventing deficiency in the general population - it is rarely sufficient to correct established deficiency in adults, particularly those with higher BMI or significant inflammatory burden.
The practical framework: what to actually do
Based on thirteen years of clinical practice and the current research evidence, here is how I approach vitamin D optimisation with clients as part of an anti-inflammatory protocol:
Step 1 - Test, don't assume. Request a 25(OH)D test. In Spain and most of Europe this can be requested via your GP or privately. Know your number before you do anything else.
Step 2 - Assess your real sun exposure. Not your lifestyle narrative - your actual UVB exposure. When are you outside? What time of day? What skin surface is exposed, for how long? This audit usually reveals a significant gap between assumed and actual.
Step 3 - Use food strategically, but don't rely on it. Approximately 80% of vitamin D status comes from UVB synthesis. Dietary sources - fatty fish, egg yolks, UV-exposed mushrooms - contribute roughly 20% and cannot compensate for inadequate synthesis. They are supportive, not primary.
Step 4 - Supplement appropriately for your deficit. Work with a practitioner to determine a dose that reflects your baseline, body composition and target range. Ensure co-factors are in place - particularly magnesium, which a large proportion of the population is also insufficient in.
Step 5 - Retest in three months. Vitamin D status responds relatively slowly to intervention. Retesting at three months gives you meaningful data without chasing short-term variation.
Step 6 - Build sun exposure as a deliberate practice. Not as a replacement for supplementation, but as a complement. Ten to twenty minutes of midday sun on significant skin surface - arms, legs, torso - without sunscreen, before applying any SPF, several times per week during UVB-active months. Then protect. This is not recklessness; it is intentional prioritisation of a biological need.
Vitamin D deficiency is one of the most consistently overlooked contributors to chronic inflammation - not because the evidence is absent, but because the assumption of sufficiency runs deep.
You eat well, you live actively, you go outside. But you might still be deficient in a hormone-nutrient that is quietly modulating how your immune system behaves every single day.
The only way to know is to check.
References
-
Zhang Y, et al. The associations among serum vitamin D concentration, systemic immune-inflammation index, and lifestyle factors in Chinese adults: a cross-sectional analysis. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1543925
-
Zhang C, Cui J, Li S, Shen J, Luo X, Yao Y, Shi H. Combined effects of vitamin D deficiency and systemic inflammation on all-cause mortality and cause-specific mortality in older adults. BMC Geriatr. 2024 Feb 1;24(1):122. doi: 10.1186/s12877-024-04706-x. PMID: 38302956; PMCID: PMC10836043.
-
Mokgalaboni K. Exploring the anti-inflammatory potential of vitamin D in cardiometabolic diseases. Metabolism Open. 2025;25:100348. doi:10.1016/j.metop.2025.100348
-
Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266-281.
-
Clemens TL, et al. Increased skin pigmentation reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982;1(8263):74-76.
-
Hurst EA, et al. Summer sun exposure fails to improve vitamin D status in older and ethnic minority adults in northern Britain. European Journal of Clinical Nutrition. 2026. doi:[June 2026, Newcastle University]
-
Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermato-Endocrinology. 2013;5(1):51-108. [UVB vs oral D3 gene expression divergence]
-
Patwardhan VG, et al. Randomized control trial assessing impact of increased sunlight exposure versus vitamin D supplementation on lipid profile in Indian vitamin D deficient men. Indian Journal of Endocrinology and Metabolism. 2017;21(3):393-398.
-
Wimalawansa SJ. Rapidly increasing serum 25(OH)D boosts the immune system, against infections - Sepsis and COVID-19. Nutrients. 2022;14(14):2997.
-
Gruber-Bzura BM. Vitamin D and influenza - prevention or therapy? International Journal of Molecular Sciences. 2018;19(8):2419.
MEDICAL DISCLAIMER
The information in this article is intended for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical diagnosis, treatment, or guidance. Vitamin D supplementation, testing, and dosing should always be discussed with a qualified healthcare provider, particularly if you have an existing medical condition, are pregnant, or are taking medication. Individual needs vary significantly. Always consult your doctor before making changes to your supplement routine.
